Genetic marker identifies tumors unable to repair DNA damage by platinum agents

[News]

Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.

More... (http://www.news-medical.net/news/20120323/Genetic-marker-identifies-tumors-unable-to-repair-DNA-damage-by-platinum-agents.aspx)